Establishing Clinical Relevance of Combinations of Biomarkers for Patient Stratification in Combination Therapy Clinical Trials
Time: 2:30 pm
day: Pre-Conference Day
Details:
• Overcome challenges of developing biomarkers that capture the combinatorial effects of
different treatment modalities combined with DDR inhibitors
• Manage differential sensitivity and provide actionable insights for clinical developments to provide guidance in clinical trials
• Reflect on the utility of genomic biomarkers and their clinical relevance for patient stratification amongst variable tumor burden and metastases
